Literature DB >> 22058043

Extended follow-up and outcomes of patients undergoing pancreaticoduodenectomy for nonmalignant disease.

Nicholas Thomas Orfanidis1, David E Loren, Carmi Santos, Eugene P Kennedy, Ali A Siddiqui, Harish Lavu, Charles J Yeo, Thomas E Kowalski.   

Abstract

BACKGROUND: Due to improved surgical outcomes and increased detection of pancreatic lesions, the resection of nonmalignant and indeterminate lesions of the pancreas has increased. AIMS: This study aims to assess the outcomes over an extended period of time and the clinical consequences of pancreaticoduodenectomy (PD) performed for nonmalignant indications.
METHODS: Patients undergoing a PD between 2006 and 2010 were retrospectively identified and asked to complete a symptom survey. Charts were reviewed for hospital admissions, emergency room visits, complications, and procedures performed.
RESULTS: A total of 132 patients were identified through database review with a median follow-up of 2.8 years. Forty-two patients (31.1%) completed the phone survey. Pain and diarrhea were the most common symptoms reported, negatively impacting the patient's daily life in 4.9% and 7.3% of patients, respectively. Diabetes developed or worsened in 19.5%, with new insulin required in 12.2%. Complications were rare, with abdominal abscess (7.6%) occurring most commonly.
CONCLUSIONS: Although some patients experienced symptoms that negatively impacted their daily life or had diabetic issues following surgery, the outcome of patients undergoing PD for nonmalignant indications was generally favorable. Further prospective study is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058043     DOI: 10.1007/s11605-011-1751-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

2.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 3.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

4.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

5.  Outcome analysis of long-term survivors following pancreaticoduodenectomy.

Authors:  W S Melvin; K S Buekers; P Muscarella; J A Johnson; W J Schirmer; E C Ellison
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

6.  Long-term anastomotic complications after pancreaticoduodenectomy for benign diseases.

Authors:  Kaye M Reid-Lombardo; Antonio Ramos-De la Medina; Kristine Thomsen; William S Harmsen; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2007-10-11       Impact factor: 3.452

7.  Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program.

Authors:  Kevin G Billingsley; Kwan Hur; William G Henderson; Jennifer Daley; Shukri F Khuri; Richard H Bell
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

8.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

9.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

10.  Five-year follow-up of a prospective non-randomised study comparing duodenum-preserving pancreatic head resection with classic Whipple procedure in the treatment of chronic pancreatitis.

Authors:  C Möbius; D Max; D Uhlmann; K Gumpp; J Behrbohm; K Horvath; J Hauss; H Witzigmann
Journal:  Langenbecks Arch Surg       Date:  2007-03-21       Impact factor: 2.895

View more
  8 in total

1.  Pancreas-preserving duodenectomy is a safe alternative to high-risk pancreatoduodenectomy for premalignant duodenal lesions.

Authors:  Elena Rangelova; John Blomberg; Christoph Ansorge; Lars Lundell; Ralf Segersvärd; Marco Del Chiaro
Journal:  J Gastrointest Surg       Date:  2015-01-07       Impact factor: 3.452

2.  Long-Term Endocrine and Exocrine Insufficiency After Pancreatectomy.

Authors:  Jiro Kusakabe; Blaire Anderson; Jingxia Liu; Gregory A Williams; William C Chapman; Majella M B Doyle; Adeel S Khan; Dominic E Sanford; Chet W Hammill; Steven M Strasberg; William G Hawkins; Ryan C Fields
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

3.  Postoperative chemoradiotherapy following pancreaticoduodenectomy. Impact of dose-volumetric parameters on the development of diabetes mellitus.

Authors:  K Eom; E K Chie; K Kim; J J Jang; S W Kim; D Y Oh; S A Im; T Y Kim; Y J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2013-08-03       Impact factor: 3.621

4.  Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms.

Authors:  Timothy E Newhook; Damien J LaPar; James M Lindberg; Todd W Bauer; Reid B Adams; Victor M Zaydfudim
Journal:  J Gastrointest Surg       Date:  2015-03-24       Impact factor: 3.452

Review 5.  [Surgical treatment of benign, premalignant and low-risk tumors of the pancreas : Standard resection or parenchyma preserving, local extirpation].

Authors:  H G Beger
Journal:  Chirurg       Date:  2016-07       Impact factor: 0.955

6.  Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors.

Authors:  Brice Malgras; Sandrine Duron; Sébastien Gaujoux; Safi Dokmak; Béatrice Aussilhou; Vinciane Rebours; Maxime Palazzo; Jacques Belghiti; Alain Sauvanet
Journal:  HPB (Oxford)       Date:  2016-01-29       Impact factor: 3.647

7.  The Surgical Choice of Incidental Periampullary Carcinoma Management in Emergency Laparotomy.

Authors:  Yun-Fei Xu; Dong-Jin Shin; Hui Yang; Yu-Xin Chen; Jin-Ming Yu
Journal:  Med Sci Monit       Date:  2018-09-11

8.  Single-operator peroral pancreatoscopy in the preoperative diagnostics of suspected main duct intraductal papillary mucinous neoplasms: efficacy and novel insights on complications.

Authors:  Sini Vehviläinen; Niklas Fagerström; Roberto Valente; Hanna Seppänen; Marianne Udd; Outi Lindström; Harri Mustonen; Fredrik Swahn; Urban Arnelo; Leena Kylänpää
Journal:  Surg Endosc       Date:  2022-03-11       Impact factor: 3.453

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.